Andere Sprachen Genscript Biotech Corporation

Aktien

A2ACSB

KYG3825B1059

1548

Verzögert Hong Kong S.E. Andere Börsenplätze 08:50:24 05.06.2024			% 5 Tage	% 1. Jan.
8,85 ^HKD	-2,75 %		-12,28 %	-55,39 %

03.06.	Hongkong-Aktien erholen sich nach unerwartetem Wachstum des verarbeitenden Gewerbes in China	MT
03.06.	GenScript Biotech zieht Aufmerksamkeit von US-Kongressmitgliedern auf sich; Aktien fallen um 18%	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hong Kong Stocks Rebound Following More than Expected Growth in China’s Manufacturing Sector	03.06.
GenScript Biotech Draws Attention from US Congress Members; Shares Tank 18%	03.06.
GenScript Biotech Shares Drop After U.S. Lawmakers Scrutinize Chinese Ties	03.06.
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	01.06.
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	31.05.
Legend Expects to Log Profit in 2026	15.05.
Legend Biotech's Loss Narrows in Q1 as Revenue Surges	14.05.
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications	13.05.
GenScript Biotech Releases 2023 ESG Report, Deepening Green Development Practices, Constructing Sustainable Future Blueprint	25.04.
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	25.04.
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint	24.04.
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	24.04.
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	23.04.
Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission	23.04.
Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug	17.04.
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment	16.04.
Genscript Biotech Corporation Announces Directorate Appointments and Change in Composition of Board Committee	12.04.
Genscript Biotech Unit's Refractory Multiple Myeloma Drug Gets FDA Approval	09.04.
GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance	27.03.
Genscript Biotech's US Unit Secures FDA Nod for Anti-Cancer Medication	19.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Genscript Biotech Corporation

Aktien

A2ACSB

KYG3825B1059

1548

Andere Sprachen

Filter